SVRASMALL

Savara Inc.

HealthcareBiotechnology
$5.27
$0.00(+0.38%)
52W$1.89
$7.00
Updated May 7, 12:00 AM
RSI48
RS Rating60/99
Beta1.23
Volatility69%
F-Score2/9
Mkt Cap$911M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Savara Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 60), indicating performance broadly in line with the market. Earnings contraction of 27% provides fundamental context to the price action. Investors should exercise caution due to high volatility (69% annualized), which requires wider risk management.

Relative Strength
60
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.23
vs S&P 500
ABOVE MKT
52W Position
66%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$5.43
50 SMA > 100 SMA$5.65
100 SMA > 150 SMA$5.26
150 SMA > 200 SMA$4.73

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$5.40-2.49%BELOW
50 SMA$5.43-2.89%BELOW
100 SMA$5.65-6.80%BELOW
150 SMA$5.26+0.12%ABOVE
200 SMA$4.73+11.32%ABOVE

Price Performance

1D+0.4%
1W+8.7%
1M-5.9%
3M-0.6%
6M+32.4%
YTD-6.6%
1Y+75.7%
3Y+39.1%
52-Week Trading Range66% from low
$5.27
52W Low$1.89
52W High$7.00

Technical Indicators

RSI (14)NEUTRAL
47.8
305070
VCP ScoreCOOL
4/10
Base depth: 27.1%

Risk Profile

Beta
1.23
52W Vol
69%
ATR
$0.29
Max DD (1Y)
-43%

Volume Analysis

Today
964.9K
50D Avg
1.46M
Vol Ratio
0.66x
Liquidity
MODERATE

Earnings Momentum

Q4'24-56%
$-0.14
Q1'25-9%
$-0.12
Q2'25-17%
$-0.14
Q3'25-27%
$-0.14
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-25.73%

Stock Price CAGR

10 Years:-4.95%
5 Years:+26.45%
3 Years:+39.05%
1 Year:+75.67%

Return on Equity

10Y Avg:-59.3%
5Y Avg:-47.4%
3Y Avg:-45.3%
Last Year:-122.5%

Key Metrics

Market Cap$911M
Gross Margin
Net Margin
Piotroski F-Score2/9

Frequently Asked Questions

Is SVRA in an uptrend right now?

SVRA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is SVRA overbought or oversold?

SVRA's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.

Is SVRA outperforming the market?

SVRA has a Relative Strength (RS) Rating of 60 out of 99. SVRA is performing about average compared to the market.

Where is SVRA in its 52-week range?

SVRA is trading at $5.27, which is 75% of its 52-week high ($7.00) and 66% above its 52-week low ($1.89).

How volatile is SVRA?

SVRA has a Beta of 1.23 and 52-week volatility of 69%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.